Option Care Selected to Provide Services to Medicare Patients Who Receive Home Enteral Nutrition Therapy
By: Option Care
June 7, 2016
BANNOCKBURN, Ill., June 2, 2016 — Option Care Enterprises, Inc., a leading national provider of home and alternate treatment site infusion therapy, has been selected by the Centers for Medicare & Medicaid Services (CMS) to continue to provide home enteral (tube feeding) nutrition services to Medicare patients across the country.
Through its competitive bid process, CMS awards contracts to Medicare suppliers who meet specific quality and financial standards. Option Care has provided home enteral nutrition to Medicare patients since the launch of the CMS competitive bidding program in 2011.
“Our continued selection by CMS demonstrates that Option Care is a partner of choice because our proven track record of delivering quality care ensures successful outcomes, “ said John Rademacher, chief operating officer for Option Care. “Our high rates of patient satisfaction and safety demonstrate that we put patients at the center of our personalized, compassionate approach to care. “
The CMS competitive bidding program launched the first nine metropolitan areas in 2011, and beginning July 1, will include 117 areas. It is part of a program mandated by Congress through the Medicare Prescription Drug, Improvement and Modernization Act of 2003. The competitive bidding program for certain durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) aims to reduce out-of-pocket expenses for patients and ensure they receive quality services. It also seeks to generate cost savings for Medicare.
Option Care’s nutrition support team includes more than 1,800 clinicians and 100 dietitians nationwide and its leadership team has more than 125 years of combined experience in providing home nutrition therapy. Through its Early Intervention Home Tube Feeding program, Option Care bridges potential gaps in care by helping eliminate financial barriers, conducting individualized nutrition assessments and providing patient education before therapy even begins.
Option Care provides home enteral nutrition support, as well as home parenteral (intravenous) nutrition support, for patients with numerous acute and chronic conditions that negatively affect their nutritional health. These conditions include stroke, cancer, and gastrointestinal diseases.
In providing home nutrition therapy, Option Care’s services and high standards have been shown to prevent hospitalizations and reduce costs. A 2016 Option Care study found that close monitoring and proactive management of 126 home enteral and 124 home parenteral patients led to interventions that resulted in 957 hospital days avoided, translating to more than $1.9 million in savings. These interventions include managing hyperglycemia or electrolyte imbalance, preventing dehydration and reducing or eliminating diarrhea.
Option Care is dedicated to delivering the highest-quality home health care services to adult and pediatric patients who need infused therapies to treat a broad range of complex and acute conditions. In addition to providing home nutrition services, Option Care provides home infusion to treat a range of conditions from infectious disease, cancer and primary immune deficiencies to autoimmune disorders and end-stage organ failure.
About Option Care
Option Care Enterprises, Inc. (Option Care) is one of the nation’s largest and most trusted providers of home and alternate treatment site infusion services. An industry leader, the company draws on nearly 40 years of clinical care experience to offer patient-centered therapy management. Option Care’s signature Home Infusion Plus services include the clinical management of infusion medicines, nursing support and care coordination. Option Care’s multidisciplinary team of more than 1,800 clinicians — including pharmacists, nurses and dietitians — are able to provide home infusion service coverage for nearly all patients across the United States needing treatment for complex and chronic conditions. Learn more at www.OptionCare.com.
# # #
You might also be interested in:
Regence and Option Care Health Partner to Provide Options for High-Risk Patients Who Rely on Infusion Therapy
Ensuring Patient Safety and Continuity of Care is Key During COVID-19 Public Health Crisis as Hospitals Face Unprecedented Challenges BANNOCKBURN, Ill., April 22, 2020 – Regence and Option Care Health, Inc. (“Option Care Health”) (NASDAQ: OPCH) today announced an expanded partnership to ease access to care and provide additional options for high-risk patients who rely on […]
New Study of Option Care Data Suggests Improved Survival for Heart Failure Patients Receiving Home Infusion of Inotropic Therapy When Coupled with Guideline-Directed Medical Therapy
BANNOCKBURN, Ill., May 16, 2018 — Survival may improve when advanced heart failure patients receiving home infusion of inotropic therapy are also receiving guideline-directed care, suggest results of a large study recently published in The Journal of Heart and Lung Transplantation. The study was conducted by investigators from Keck School of Medicine of USC and Option […]